AstraZeneca to supply up to 400 million doses of Oxford’s vaccine free
AstraZeneca has come to an agreement with the European Inclusive Vaccines Alliance (IVA), initiated by Germany, France, Italy and the
Read more
recombinant adenovirus vectors
AstraZeneca reaches $750m agreement with CEPI for Oxford COVID-19 vaccine
British pharmaceutical company AstraZeneca has reached a landmark $750 million agreement with Coalition for Epidemic Preparedness Innovation (CEPI) and the
Read more
AstraZeneca to advance Oxford’s COVID-19 vaccine with $1bn investment
AstraZeneca is going to expedite the development of the University of Oxford investigational COVID-19 vaccine with a $1 billion BARDA
Read more